Inviting an author to review:
Find an author and click ‘Invite to review selected article’ near their name.
Search for authorsSearch for similar articles
6
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: not found
      • Article: not found

      Synthesis of unique spirocyclic orthoester-type derivatives of isothiazolo[4,3-d]pyrimidine nucleosides

      ,
      The Journal of Antibiotics
      Springer Nature

      Read this article at

      ScienceOpenPublisher
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Related collections

          Most cited references18

          • Record: found
          • Abstract: found
          • Article: not found

          Advances in the development of nucleoside and nucleotide analogues for cancer and viral diseases.

          Nucleoside analogues have been in clinical use for almost 50 years and have become cornerstones of treatment for patients with cancer or viral infections. The approval of several additional drugs over the past decade demonstrates that this family still possesses strong potential. Here, we review new nucleoside analogues and associated compounds that are currently in preclinical or clinical development for the treatment of cancer and viral infections, and that aim to provide increased response rates and reduced side effects. We also highlight the different approaches used in the development of these drugs and the potential of personalized therapy.
            Bookmark
            • Record: found
            • Abstract: not found
            • Article: not found

            Fluorescent analogs of biomolecular building blocks: design, properties, and applications.

              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              Metabolism, Biochemical Actions, and Chemical Synthesis of Anticancer Nucleosides, Nucleotides, and Base Analogs.

              Nucleoside, nucleotide, and base analogs have been in the clinic for decades to treat both viral pathogens and neoplasms. More than 20% of patients on anticancer chemotherapy have been treated with one or more of these analogs. This review focuses on the chemical synthesis and biology of anticancer nucleoside, nucleotide, and base analogs that are FDA-approved and in clinical development since 2000. We highlight the cellular biology and clinical biology of analogs, drug resistance mechanisms, and compound specificity towards different cancer types. Furthermore, we explore analog syntheses as well as improved and scale-up syntheses. We conclude with a discussion on what might lie ahead for medicinal chemists, biologists, and physicians as they try to improve analog efficacy through prodrug strategies and drug combinations.
                Bookmark

                Author and article information

                Journal
                The Journal of Antibiotics
                J Antibiot
                Springer Nature
                0021-8820
                1881-1469
                July 26 2017
                July 26 2017
                :
                :
                Article
                10.1038/ja.2017.87
                c291d0b3-6503-4d6f-9727-d96f5a74ae0a
                © 2017
                History

                Comments

                Comment on this article